2,6-diaminopurine 2',3'-dideoxyriboside has been researched along with 3'-fluoro-2',3'-dideoxyguanosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, M; Balzarini, J; de Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Wood, SG | 1 |
1 other study(ies) available for 2,6-diaminopurine 2',3'-dideoxyriboside and 3'-fluoro-2',3'-dideoxyguanosine
Article | Year |
---|---|
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
Topics: Adenosine Deaminase; Antimetabolites; Antiviral Agents; Coformycin; Deoxyadenosines; Deoxyguanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Pentostatin; Prodrugs; Solubility; Virus Replication | 1988 |